CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025

13 2月 2025 15:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

12 2月 2025 08:45:01 条件 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

11 2月 2025 13:34:09 条件 NetDania Notify

Cytokinetics Names Robert E. Landry to Board of Directors

11 2月 2025 06:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

10 2月 2025 08:56:36 条件 NetDania Notify

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

07 2月 2025 09:17:25 条件 NetDania Notify

Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

05 2月 2025 15:00:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 2月 2025 15:00:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program

30 1月 2025 06:30:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction

21 1月 2025 06:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

13 1月 2025 13:43:22 条件 NetDania Notify

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

13 1月 2025 06:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CYTOKINETICS INCORPORATED - COMMON STOCK

10 1月 2025 09:28:43 条件 NetDania Notify

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 1月 2025 15:00:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

03 1月 2025 15:00:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

23 12月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China

19 12月 2024 23:00:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 12月 2024 15:00:00 条件 Nasdaq GlobeNewswire

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

03 12月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Cytokinetics to Participate in December Investor Conferences

02 12月 2024 15:00:00 条件 Nasdaq GlobeNewswire